Abstract 395P
Background
Google Trends, a free web-based tracking system of Google search volumes, can be used to monitor online interest in various health conditions, including lung cancer. This is particularly useful in the Philippines, the country named as the world's number one internet user in 2018. Understanding the pattern of information-seeking behavior of Filipinos with regards to lung cancer is crucial because it may inform public policy and potentially make lung cancer awareness campaigns more directed and effective in the population-based setting. Here we described patterns in online search behaviors related to lung cancer using Google Trends data on Google web and YouTube searches in the Philippines for the past ten years.
Methods
Relative search volumes on the term “lung cancer” from 2009 to 2019 were extracted from Google Trends. Both Google web search and YouTube search data were downloaded. The data were saved in a comma-separated values file then imported to Microsoft Excel where a graph was plotted and a polynomial trendline (second order) was added to estimate search trends over a time period. Regions and cities in the Philippines where the term “lung cancer” was most popular were identified. Related topics and queries were also enumerated.
Results
Trends in Google web search showed a steady interest in lung cancer for both Google web search and YouTube searches from 2009 to 2019, with peaks in 2014. No spikes were observed in August, the Philippines’ Lung Cancer Awareness month. Online search behaviour for lung cancer was greatest in Metro Manila and areas in Northern Philippines. Top related and rising topics and queries in lung cancer, both on Google web search and YouTube, were related to etiology, symptoms, and management of lung cancer.
Conclusions
Filipinos had a steady interest in lung cancer, as shown by Google Trends data for both Google web search and YouTube searches from 2009 to 2019. Cancer diagnoses of Filipino personalities in 2014 may have led to peaks in online interest. Filipinos were also interested to learn about etiology, symptoms, and management of lung cancer. These data may be used to leverage online interest to optimize lung cancer awareness campaigns in the Philippines.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
The authors.
Funding
Has not received any funding.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
511P - Phase II trial of carboplatin, nab-paclitaxel and bevacizumab for advanced non-squamous non-small cell lung cancer (CARNAVAL study; TORG1424/OLCSG1402)
Presenter: Toshio Kubo
Session: Poster display session
Resources:
Abstract
485P - A real-world experience of first-line afatinib in Korean patients with EGFR-mutant non-small cell lung cancer
Presenter: Seong Hoon Yoon
Session: Poster display session
Resources:
Abstract
522P - Weekly nab-PTX and weekly PTX for relapsed small cell lung cancer
Presenter: Hajime Oi
Session: Poster display session
Resources:
Abstract
512P - A phase I and extension study of S-1 and carboplatin for previously untreated patients aged 75 years or more with advanced non-small cell lung cancer
Presenter: Hisao Imai
Session: Poster display session
Resources:
Abstract
497P - Real-word efficacy of osimertinib in patients with metastatic EGFRm NSCLC: An interim analysis from a multi-center study in China
Presenter: Xiangyun Ye
Session: Poster display session
Resources:
Abstract
507P - Immune checkpoint inhibitors for patients acquired resistance to tyrosine kinase inhibitors with EGFR mutated non-small cell lung cancer: A multicenter retrospective study
Presenter: Takeshi Uenami
Session: Poster display session
Resources:
Abstract
516P - Clinical outcomes in elderly patients with advanced non-small cell lung cancer: A prospective multicenter study of the National Hospital Organization in Japan
Presenter: Masahiro Shimada
Session: Poster display session
Resources:
Abstract
486P - Phase II study of low-dose afatinib maintenance treatment for patients with EGFR-mutated non-small cell lung cancer (NJLCG1601)
Presenter: Mami Morita
Session: Poster display session
Resources:
Abstract
515P - Polypharmacy as a prognostic factor in elderly patients with advanced non-small cell lung cancer treated with immune checkpoint inhibitors
Presenter: Taiki Hakozaki
Session: Poster display session
Resources:
Abstract
518P - Real world prospective clinical impact of finding actionable genomic alterations by plasma cell-free DNA next generation sequencing in advanced non-small cell lung cancer
Presenter: Beung chul Ahn
Session: Poster display session
Resources:
Abstract